Agafonova Nataliya
CIK 1985443 · Chief Medical Officer · last filed 2026-05-05
Agafonova Nataliya is a Chief Medical Officer who has filed 15 SEC Form 4 insider transactions across 2 companies since 2023. The most recent filing, for LGVN, was dated May 5, 2026. Current disclosed insider exposure totals $350.4K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$350.4K
2
15
$0
Holdings By Company
Recent Filings
15 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-05-05 | LGVN | Grant (A) | +250,000 | $0 | EDGAR |
| 2026-04-03 | LGVN | Tax (F) | −13,145 | -$14.7K | EDGAR |
| 2026-01-06 | LGVN | Tax (F) | −10,250 | -$6.1K | EDGAR |
| 2025-10-03 | LGVN | Tax (F) | −11,883 | -$8.8K | EDGAR |
| 2025-07-17 | LGVN | Grant (A) | +102,000 | $0 | EDGAR |
| 2025-07-03 | LGVN | Tax (F) | −7,431 | -$9.5K | EDGAR |
| 2025-04-03 | LGVN | Tax (F) | −7,566 | -$11.3K | EDGAR |
| 2025-01-06 | LGVN | Tax (F) | −6,120 | -$11.0K | EDGAR |
| 2024-10-03 | LGVN | Tax (F) | −5,316 | -$10.0K | EDGAR |
| 2024-08-19 | LGVN | Mixed | +161,359 | -$35.4K | EDGAR |